Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing.
Changes in the beta-adrenergic receptor-G protein-adenylate cyclase complex were investigated in an experimental canine model of low-output heart failure produced by chronic rapid ventricular pacing. The contractile response occurring after exposure to the beta-adrenergic agonist dobutamine, measured as peak left ventricular + dP/dt, was decreased after 3 weeks of pacing. To further characterize the diminished functional responsiveness to beta-adrenergic receptor stimulation, beta-adrenergic receptor-adenylate cyclase coupling was investigated using membranes prepared from both control and paced animals. The density of beta-adrenergic receptors was decreased by 40% with a selective downregulation of the beta 1-subtype. The affinity of the receptor for the antagonist radioligand [125I]iodocyanopindolol remained unchanged. A defect in coupling was suggested by a decreased ability of isoproterenol, fluoride, and forskolin to stimulate adenylate cyclase in membranes prepared from failing hearts. Determination of the levels of Gi alpha (the alpha-subunit of Gi) by immunoblotting and pertussis toxin labeling revealed modest increases of approximately 30%. Furthermore, Mn2+ and purified Gs failed to stimulate adenylate cyclase in membranes prepared from failing hearts, indicating an impairment in the catalytic moiety of adenylate cyclase itself or in the ability of adenylate cyclase to couple to Gs. In contrast, complementation assay did not reveal differences in the functional activity of Gs alpha (the alpha-subunit of Gs). Taken together, these data demonstrate a selective decrease in the beta 1-subtype of adrenergic receptors and an increase in a 40-kd G1-like protein in the failing heart. Similar changes have been described in human idiopathic dilated cardiomyopathy. In addition to these changes, we identified a possible defect at the level of the catalytic subunit of adenylate cyclase.
Marzo
K P
KP
Cardiovascular Section, Hospital of the University of Pennsylvania, Philadelphia 19104-4283.
Frey
M J
MJ
Wilson
J R
JR
Liang
B T
BT
Manning
D R
DR
Lanoce
V
V
Molinoff
P B
PB
D037361:Adenylate Cyclase Toxin; D000262:Adenylyl Cyclases / Q000502:physiology*; D000818:Animals; D002395:Catecholamines / Q000097:blood; D004095:Dihydropyridines / Q000378:metabolism; D004280:Dobutamine / Q000494:pharmacology; D004285:Dogs; D004558:Electric Stimulation; D019204:GTP-Binding Proteins / Q000502:physiology*; D006333:Heart Failure / Q000503:physiopathology*; D006339:Heart Rate; D006439:Hemodynamics; D037342:Pertussis Toxin; D011943:Receptors, Adrenergic, beta / Q000502:physiology*; D010566:Virulence Factors, Bordetella / Q000378:metabolism
D037361:Adenylate Cyclase Toxin; D002395:Catecholamines; D004095:Dihydropyridines; D011943:Receptors, Adrenergic, beta; D010566:Virulence Factors, Bordetella; D004280:Dobutamine; C038806:1,4-dihydropyridine; D037342:Pertussis Toxin; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases